Statistics for Iovance Biotherapeutics (id:6458 IOVA)

Valuation metrics

Market cap

2.51B

Enterprise value

2.16B

Trailing P/E (ttm)

-4.52

Forward P/E

-10.05

PEG ratio

-10.05

Price/Sales (ttm)

27.64

Price/Book (mrq)

3.25

Enterprise Value/Revenue

23.80

Enterprise Value/EBITDA

-5.30

Overview

Shares outstanding

304.78M

Float

225.66M

Shares short

59.73M

% Held by insiders

0.01%

% Held by institutions

0.88%

Average volume (10 days)

11.38M

Average volume (90 days)

Price summary

52-Week low

5.41

52-Week high

18.33

52-Week change

32.28%

Beta

0.59

50-Day moving average

9.97

200-Day moving average

10.78

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

September 26th, 2013

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-804.54%

Operating margin

-152.11%

Operational effectiveness

Return on assets

-29.16%

Return on equity

-56.65%

Income statement

Revenue (ttm)

0.33

Revenue per share (ttm)

0.33

Quarterly revenue growth (yoy)

Gross profit (ttm)

-9,566,000.00

EBITDA

-408,321,984.00

Net income to common (ttm)

-409,996,992.00

Diluted EPS (ttm)

-1.48

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

397.49M

Total cash per share (mrq)

1.30

Total debt (mrq)

78.94M

Total Debt/Equity (mrq)

10.21

Current ratio (mrq)

422.30%

Book value per share (mrq)

2.54

Cash flow

Cash flow statement

-363,651,008.00

Levered free cash flow (LFCF)

-198,331,744.00